Publisher
Springer Berlin Heidelberg
Reference68 articles.
1. Al-Kasim F, Doyle JJ, Massey GV, Weinstein HJ, Zipursky A (2002) Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric Oncology Group Study. J Pediatr Hematol Oncol 24:9–13
2. Ashfaq R, Weinberg AG, Argyle CA (1992) Acute megakaryoblastic leukemia simulating carcinoma. Am J Clin Pathol 98:55–60
3. Athale UH, Razzouk BI, Raimondi SC, Tong X, Behm FG, Head DR, Srivastava DK, Rubnitz JE, Bowman L, Pui CH, Ribeiro RC (2001) Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution’s experience. Blood 97:3727–3732
4. Bartelik S (1995) [Hemoglobin concentration, hematocrit and leukocyte distribution pattern in children with Down’s syndrome]. Pediatr Pol 70:467–471
5. Ben-Ezra J, Sheibani K, Hwang DL, Lev-Ran A (1990) Megakaryocyte synthesis is the source of epidermal growth factor in human platelets. Am J Pathol 137:755–759